AbCellera Biologics Inc (ABCL) Shares Decline Despite Market Challenges
The stock price of AbCellera Biologics Inc (NASDAQ: ABCL) has dropped by -0.42 compared to previous close of 4.73. Despite this, the company has seen
The stock price of AbCellera Biologics Inc (NASDAQ: ABCL) has dropped by -0.42 compared to previous close of 4.73. Despite this, the company has seen
Company’s 36-month beta value is 0.38.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as
The stock has a 36-month beta value of 0.38. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
The stock of AbCellera Biologics Inc (ABCL) has gone down by -3.01% for the week, with a -3.20% drop in the past month and a
Additionally, the 36-month beta value for ABCL is 0.39. The public float for ABCL is 198.44M and currently, short sellers hold a 12.34% ratio of
while the 36-month beta value is 0.40. The public float for ABCL is 198.44M, and currently, short sellers hold a 12.34% ratio of that floaft.
The 36-month beta value for ABCL is also noteworthy at 0.38. The public float for ABCL is 198.44M, and at present, short sellers hold a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.